1. Home
  2. ACOG vs FBIO Comparison

ACOG vs FBIO Comparison

Compare ACOG & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

HOLD

Current Price

$5.90

Market Cap

115.5M

Sector

N/A

ML Signal

HOLD

Logo Fortress Biotech Inc.

FBIO

Fortress Biotech Inc.

HOLD

Current Price

$3.49

Market Cap

113.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACOG
FBIO
Founded
2000
2006
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
115.5M
113.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ACOG
FBIO
Price
$5.90
$3.49
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$18.00
$16.50
AVG Volume (30 Days)
81.5K
1.2M
Earning Date
11-13-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,427,199.00
$62,303,000.00
Revenue This Year
N/A
$29.71
Revenue Next Year
$132.35
$49.34
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.75
$1.33
52 Week High
$11.54
$4.53

Technical Indicators

Market Signals
Indicator
ACOG
FBIO
Relative Strength Index (RSI) 44.35 46.92
Support Level $6.11 $3.25
Resistance Level $6.62 $4.53
Average True Range (ATR) 0.42 0.31
MACD -0.04 -0.09
Stochastic Oscillator 2.77 18.75

Price Performance

Historical Comparison
ACOG
FBIO

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

Share on Social Networks: